Delivery Order SPE2DB24D2213-SPE2DB24FGVRB
Award Date
8/28/24
Potential Completion Date
8/29/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract is a firm fixed-price delivery order with a ceiling value of $3,148.60 and a period of performance through April 18, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira Pen 40 mg/0.8 ml. The contract has a ceiling value of $8,428.26 and is a firm fixed-price delivery order with a completion date of July 5, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL pens, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $6,237.00 and a performance period that runs through May 14, 2025. This award is not set-aside and is issued under a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL prefilled pens. The contract is a firm fixed-price delivery order with a ceiling value of $36,676.68 and an ultimate completion date of September 6, 2024. The contract is not set aside for any specific business category. AmerisourceBergen, through its Corporate Office division, will provide the Humira...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) auto-injector pens. The contract has a ceiling value of $7,144.68 and an ultimate completion date of November 24, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (adalimumab) 40 mg/0.4 mL pens. The $11,226.92 firm-fixed-price delivery order has a completion date of June 10, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $73,538.70 and is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens. The contract has a performance period through January 17, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 80 mg/0.8 mL pens. The contract has a ceiling value of $5,354.56 and a completion date of December 13, 2024. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of Humira (adalimumab) 40 mg/0.4 mL pens. The contract has a firm fixed price, a total ceiling value of $7,956.54, and an ultimate completion date of September 20, 2024. This award is not associated with any set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award is for the delivery of Humira (adalimumab) 40 mg/0.4 mL prefilled pens to the Defense Logistics Agency (DLA), a defense agency. The $12,980.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...